Showing results (171-180 of 2,365) with videos related to
Sort By:
Pageof 237
The Journal of Infectious Diseases|March 5, 2016
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV InfectionKatherine V Houser, Lisa Gretebeck, Tianlei Ying, et al.Communicable Diseases Intelligence (2018)|September 26, 2022
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021Genevieve O'Neill, Ammar Aziz, Miku Kuba, et al.Vaccine|January 18, 2007
Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV)Leatrice N Vogel, Anjeanette Roberts, Christopher D Paddock, et al.Journal of Virology|July 7, 2018
Strand-Specific Dual RNA Sequencing of Bronchial Epithelial Cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus InteractionsGiulia Fabozzi, Andrew J Oler, Poching Liu, et al.Communicable Diseases Intelligence (2018)|May 18, 2025
Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2023Tanya R Diefenbach-Elstob, Olivia Lay, Tasoula Zakis, et al.Mbio|October 27, 2022
Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in HumansTroy C Sutton, Elaine W Lamirande, Devanshi R Patel, et al.Proceedings of the National Academy of Sciences of the United States of America|March 6, 2013
Structure and accessibility of HA trimers on intact 2009 H1N1 pandemic influenza virus to stem region-specific neutralizing antibodiesAudray K Harris, Joel R Meyerson, Yumiko Matsuoka, et al.Emerging Infectious Diseases|January 24, 2023
Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 InfectionDavid S Khoury, Timothy E Schlub, Deborah Cromer, et al.Influenza and Other Respiratory Viruses|December 1, 2022
Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 monthsFrancesca L Mordant, Olivia H Price, Rajeev Rudraraju, et al.Communicable Diseases Intelligence (2018)|February 16, 2022
The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in AustraliaNatasha K Brusco, Annette Alafaci, Jane Tuckerman, et al.Pageof 237